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328a Monday, March 2, 2009assay. The investigation of over 60 cysteine mutations within ArnT identify for
the first time functionally important sites within the ArnT transferase. This
work sets the stage for additional studies of the structure and function of this
protein using biophysical approaches.
This project is supported by the NIH (AI058024).
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Mutations in the transmembrane domains of receptor tyrosine kinases (RTKs)
are implicated in many human diseases. For example, fibroblast growth factor
receptor 3 (FGFR3) carrying an A391E mutation in the transmembrane (TM)
region is associated with bladder cancer and Crouzon syndrome with acanthosis
nigricans. Previous work has shown that the isolated FGFR3 TM domains di-
merize in detergent micelles and in lipid bilayers. Therefore, we are exploring
whether the TM domain of FGFR3 can inhibit the pathogenic effects of the
A391E mutation. Our preliminary data show that the activation level of a chi-
meric Neu_FGFR3 receptor carrying the A391E mutation could be inhibited by
co-expressing short mutant FGFR3 TM peptides. We also observe a decrease in
dimerization propensity of the receptors due to the co-expression. Currently, we
are investigating the specificity and the efficiency of the inhibition by using TM
peptides from other RTKs. The TM peptides which can specifically and effi-
ciently inhibit the activation and dimerization of FGFR3 mutants are possible
candidates for future therapies for diseases linked to FGFR3 TM domain
mutations.
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The innate immune system represents our first line of defense against microbial
pathogens. TLR4 is the cell-surface receptor primarily responsible for initiating
the innate immune response to lipopolysaccharide (LPS), a major component of
the bacterial cell envelope. However, relatively little is known about the molec-
ular mechanisms underlying TLR activation. Design of small molecule
therapeutics to modulate immune activation will benefit greatly from a better
understanding of TLR4 activation and membrane proximal events. Resolution
of the molecular mechanisms requires direct structural information for the
TLR4 receptor complex, including the ability to detect ligand-induced confor-
mational changes in the components and TLR4 dimerization. To acquire
structural information at the required level of detail, we have reconstituted the
system in model membranes and analyzed the TLR4 receptor complex and its
dynamics during the transition from quiescence to activation using neutron re-
flection, cryoelectron microscopy, lifetime- and spectrally-resolved confocal
microscopy, and total internal reflectance fluorescence (TIRF) microscopy.
The results to date suggest that a conformational change in the accessory protein
MD2 upon binding antigen causes association of the receptors.
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Pulmonary surfactant protein B (SP-B) is a hydrophobic 79-residue protein, es-
sential for the respiratory function. SP-B is supposedly involved in the transfer
of phospholipid molecules from specific lipid/protein assemblies produced by
pneumocytes into the alveolar air-liquid interface to form surface active films
competent to stabilize the respiratory surface against collapse along breathing
dynamics. Lack of SP-B is lethal, being its absence associated with an irrevers-
ible respiratory failure at birth.
Quartz crystal microbalance with dissipation technique has been used to ana-
lyze SP-B lytic and fusogenic properties in an environment that could be closer
to the surfactant multilayer stores thought to be formed beneath pulmonary air-
liquid interface. Processes related with unpacking surfactant lipids as they are
transferred into the surface and converted into multilayered forms have been
attributed to SP-B function although the molecular mechanism by which the
protein could perform these actions are entirely unknown.QCM-D technique has been used to characterize how SP-Bmodulates the adsorp-
tion properties to surfaces of DOPC and DPPC membranes containing different
physiologically-relevant protein proportions, leading to the formation of mem-
brane stacks on the surface rather than a single supported bilayer.We have also in-
vestigated how the collapse of lipid/protein vesicles is affected or modulated by
physiologically relevant factors such as lipid composition (i.e. presence of anionic
lipids, which increase the effect of SP-B), presence of the other surfactant hydro-
phobic protein, SP-C, or the addition of Ca2þ. These studies have been conducted
using both full-length purified porcine SP-B and selected SP-B peptide fragments.
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ATP Binding Cassette (ABC) transporters are transmembrane transporters that
use the energy released by ATP hydrolysis to transport a wide array of sub-
strates. They are found in all kingdoms of life, and are complicit in various ge-
netic conditions, such as cystic fibrosis, macular degeneration, and multi-drug
resistance. The E. coli ribose transporter (RbsABC) is a multisubunit ABC
transporter complex with a periplasmic ribose binding domain, a transmem-
brane domain dimer, and a cytoplasmic nucleotide binding domain. The ribose
transport complex has been shown to assemble and disassemble into distinct
combinations of the subunits based on the presence of cofactors (ATP and an-
alogues, ADP, orthovanadate, and magnesium), suggesting a series of steps for
how the subunits associate and subsequently transport ribose.
To further explore the conformation of the complex in the presence of various
cofactors, EPR spin labels were introduced to the periplasmic ribose binding
protein. The EPR spectra confirms previously observed data suggesting that
the ribose binding domain is strongly bound to the transmembrane domain in
the resting state. Additionally, data suggest that the ribose binding domain
binds in two steps, forming an initial weak interaction, then a strong interaction
that results in a reduction of affinity for ribose.
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Spinocerebellar Ataxia Type 13 is an autosomal dominant genetic disease char-
acterized by ataxia, oculomotor abnormalities, and the death of cerebellar neu-
rons. SCA13 is caused by mutations in the Kv3.3 voltage-gated Kþ channel
gene, including R366H in S2; R420H and R423H in S4; and F448L in S5.
SCA13 exists in two forms with infant or adult onset. There is a strong geno-
type-phenotype correlation between the disease-causing mutation and the age
of onset of symptoms. The functional effects of the mutations fall into two cat-
egories. R366H, R420H, and R423H are non-functional when expressed alone
and exert strong dominant negative effects when co-expressed with wild type
Kv3.3 or other members of the Kv3 subfamily. The stoichiometry of suppres-
sion differs among the three R/Hmutations, with R366H subunits less disrup-
tive to function than R420H or R423H. In contrast, F448L is a dominant gain of
function mutation that affects channel gating. F448L shifts the voltage depen-
dence of activation in the hyperpolarized potential and dramatically slows de-
activation. These changes in Kv3.3 gating are not significantly different
whether F448L is expressed alone or co-expressed with wild type subunits.
Kv3 channels, including Kv3.3, facilitate high frequency firing in neurons.
The SCA13 mutations are expected to alter the excitability of cerebellar
neurons, which express high levels of Kv3.3. Since the functional effects of
the mutations are distinct, it is likely that they will have distinct effects on
the excitability of cerebellar neurons. This hypothesis is supported by mathe-
matical modeling of firing behavior in cerebellar neurons. Differential effects
on neuronal excitability are likely to underlie the symptoms of SCA13 and
may help to explain the differences in the age of disease onset.
This work was supported by NIH grant R01-NS058500 to DMP.
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